Search
Search Constraints
You searched for: Author/Creator Mesaros, NarcisaLimit your search
- Mesaros, Narcisa [remove] 23
- Vaccines -- Periodicals 20
- 615.372 19
- 616.9 3
- Communicable diseases -- Periodicals 3
- Infection -- Periodicals 2
- Medical microbiology -- Periodicals 2
- 615.37205 1
- AE adverse event -- ATP according-to-protocol -- CI confidence interval -- CPS capsular polysaccharide -- DTaP-HepB-IPV/Hib diphtheria-tetanus-acellular pertussis-hepatitis B virus-inactivated poliovirus and Haemophilus influenzae type b vaccine -- ECL electrochemiluminescence -- ELISA enzyme-linked immunosorbent assay -- FHA filamentous hemagglutinin -- HBs hepatitis B surface antigen -- GMC geometric mean concentration -- GMT geometric mean titer -- Hib Haemophilus influenzae type b -- LLoQ lower limit of quantitation -- PCV13 13-valent pneumococcal conjugate vaccine -- PRN pertactin -- PRP polyribosylribitol phosphate -- PT pertussis toxoid -- RCT randomized controlled trial -- SAE serious adverse event -- Tdap diphtheria-tetanus-acellular pertussis vaccine -- TVC total vaccinated cohort 1
- AE adverse event -- ATP according-to-protocol -- CI confidence interval -- CPS capsular polysaccharide -- DTaP-HepB-IPV/Hib diphtheria-tetanus-three-component acellular pertussis-hepatitis B virus-inactivated poliovirus/Haemophilus influenzae type b vaccine -- DU D antigen units -- ECL electrochemiluminescence -- ELISA enzyme-linked immunosorbent assay -- FHA filamentous hemagglutinin -- GMC geometric mean concentration -- GMT geometric mean titer -- HBs hepatitis B surface antigen -- Hib Haemophilus influenzae type b -- IPV inactivated poliovirus -- IU international units -- PCV13 13-valent pneumococcal conjugate vaccine -- PRN pertactin -- PRP polyribosylribitol phosphate -- PT pertussis toxoid -- SAE serious adverse event -- Tdap tetanus-reduced-antigen-content diphtheria-acellular pertussis vaccine -- TT tetanus toxoid -- TVC total vaccinated cohort -- UK United Kingdom -- US United States -- WHO World Health Organization 1
- AE adverse event -- ATP according-to-protocol -- CI confidence interval -- DTPa combined diphtheria-tetanus toxoids-acellular pertussis vaccine -- ELISA enzyme-linked immunosorbent assay -- FHA filamentous hemagglutinin -- GMC geometric mean concentration -- IU international units -- LL lower limit -- PRN pertactin -- PT pertussis toxoid -- SAE serious adverse event -- Tdap combined vaccine containing reduced-antigen-content of diphtheria toxoid, tetanus toxoid, and acellular pertussis -- US United States 1